High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year

Marikka Kuoppamäki1, Marika Salminen2, Tero Vahlberg3

  • 1Institute of Clinical Medicine, Family Medicine, University of Turku, Turku, Finland; Naantali Health Centre, Naantali, Finland.

Insights

High-sensitivity C-reactive protein (hsCRP) did not predict vascular disease events in older adults. While hsCRP predicted all-cause mortality, it did not add value beyond conventional risk factors.

Area of Science:

  • Cardiology
  • Gerontology
  • Biomarkers

Background:

  • High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation.
  • Its role in predicting vascular disease (VD) and mortality in older adults needs further investigation.
  • Existing research on hsCRP and cardiovascular outcomes in the elderly is limited.

Purpose of the Study:

  • To assess the clinical utility of hsCRP categorization in older adults.
  • To determine if elevated hsCRP adds predictive value for cardiovascular morbidity and all-cause mortality beyond conventional risk factors.
  • To investigate the association between hsCRP levels and vascular disease events in individuals aged 64 and above.

Main Methods:

  • Prospective population-based study with a 9-year follow-up.
  • Included 771 participants aged 64+ without prior VD and with C-reactive protein (CRP) <10 mg/L at baseline.
  • Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for VD events and all-cause mortality based on hsCRP levels.

Main Results:

  • hsCRP was not significantly associated with incident VD events after adjusting for age, gender, VD risk factors, or metabolic syndrome.
  • hsCRP predicted all-cause mortality after adjustments for age and gender, but not independently of conventional risk factors.
  • Participants with high hsCRP (3.0-9.9 mg/L) showed increased age- and gender-adjusted mortality and a trend towards higher risk factor-adjusted mortality compared to low-risk individuals (hsCRP <1 mg/L).

Conclusions:

  • hsCRP categorization may not be clinically useful for predicting cardiovascular events in older adults.
  • Elevated hsCRP levels do not appear to provide additive predictive value for vascular events beyond established risk factors.
  • hsCRP's association with all-cause mortality in the elderly warrants further investigation but does not independently predict outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
951
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K